Corebridge Financial Inc. Sells 15,379 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Corebridge Financial Inc. cut its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 383,650 shares of the real estate investment trust’s stock after selling 15,379 shares during the period. Corebridge Financial Inc.’s holdings in Sabra Health Care REIT were worth $6,645,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Geode Capital Management LLC grew its stake in Sabra Health Care REIT by 1.7% in the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after purchasing an additional 104,533 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Sabra Health Care REIT by 222.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock worth $183,996,000 after buying an additional 6,819,919 shares during the last quarter. Vestcor Inc grew its position in Sabra Health Care REIT by 62.5% during the third quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock valued at $3,869,000 after buying an additional 79,956 shares during the period. Barclays PLC increased its holdings in Sabra Health Care REIT by 56.1% during the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock worth $12,624,000 after buying an additional 243,895 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in Sabra Health Care REIT by 12.3% in the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock worth $9,543,000 after acquiring an additional 57,551 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Health Care REIT Trading Up 0.9 %

Shares of SBRA stock opened at $17.54 on Friday. The stock has a market capitalization of $4.17 billion, a price-to-earnings ratio of 33.09, a PEG ratio of 1.97 and a beta of 1.27. The company’s fifty day simple moving average is $16.83 and its two-hundred day simple moving average is $17.68. Sabra Health Care REIT, Inc. has a 1 year low of $13.31 and a 1 year high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. As a group, analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were given a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.84%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 226.42%.

Analyst Ratings Changes

A number of research firms have recently weighed in on SBRA. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research report on Tuesday, January 7th. Truist Financial increased their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a report on Tuesday, March 18th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Finally, Mizuho reiterated a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Sabra Health Care REIT has an average rating of “Moderate Buy” and an average target price of $19.33.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.